BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
11 results:

  • 1. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
    Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
    Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Function and Mechanism of Long Non-Coding RNA RP11-23J9.4 in thyroid cancer.
    Zhong L; Ding X; Xiong X; Hao T; Zhang C; Wang L; Zhao Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(4):53-61. PubMed ID: 37183946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: a clinicopathological and molecular study of four cases.
    Wang L; Wang XT; Fang Y; Qiu W; Xia QY; Fang R; Rao Q; Yin HL
    Hum Pathol; 2023 Apr; 134():66-73. PubMed ID: 36549599
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating axin2 through Wnt/β-catenin signaling pathway.
    Lv P; Xue Y
    Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Association Between
    Dai J; Gao H; Xue J; Lin W; Zheng L
    Genet Test Mol Biomarkers; 2019 Jun; 23(6):393-400. PubMed ID: 31063404
    [No Abstract]    [Full Text] [Related]  

  • 6. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
    Yan B; Hou Y; Chen D; He J; Jiang Y
    Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells.
    Wang X; Xu C; Hua Y; Cheng K; Zhang Y; Liu J; Han Y; Liu S; Zhang G; Xu S; Yang Z
    Sci Rep; 2018 Sep; 8(1):14001. PubMed ID: 30228287
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
    Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
    Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Papillary thyroid cancer and inflammatory bowel disease: is there a relationship?
    Sonu IS; Blonski W; Lin MV; Lewis J; Aberra F; Lichtenstein GR
    World J Gastroenterol; 2013 Feb; 19(7):1079-84. PubMed ID: 23467027
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
    Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
    Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.